Given Imaging Ltd. Announces New Data Highlighting PillCam® COLON Comparability to Colonoscopy in Detecting Adenomas
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced a secondary analysis of data from its prospective, multicenter clinical trial to assess the accuracy and safety of PillCam COLON for detecting lesions at least 6 mm in size.
Help employers find you! Check out all the jobs and post your resume.
ORLANDO, Fla., May 21, 2013 (GLOBE NEWSWIRE) -- Given Imaging Ltd, (Nasdaq:GIVN), a world leader in GI medical devices and pioneer of capsule endoscopy, today announced a secondary analysis of data from its prospective, multicenter clinical trial to assess the accuracy and safety of PillCam COLON for detecting lesions at least 6 mm in size.
Help employers find you! Check out all the jobs and post your resume.